BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29468427)

  • 1. Maximizing gain in high-throughput screening using conformal prediction.
    Svensson F; Afzal AM; Norinder U; Bender A
    J Cheminform; 2018 Feb; 10(1):7. PubMed ID: 29468427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate Hit Estimation for Iterative Screening Using Venn-ABERS Predictors.
    Buendia R; Kogej T; Engkvist O; Carlsson L; Linusson H; Johansson U; Toccaceli P; Ahlberg E
    J Chem Inf Model; 2019 Mar; 59(3):1230-1237. PubMed ID: 30726080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Screening Efficiency through Iterative Screening Using Docking and Conformal Prediction.
    Svensson F; Norinder U; Bender A
    J Chem Inf Model; 2017 Mar; 57(3):439-444. PubMed ID: 28195474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy conformal prediction applied to large-scale bioactivity datasets and in federated learning.
    Norinder U; Spjuth O; Svensson F
    J Cheminform; 2021 Oct; 13(1):77. PubMed ID: 34600569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling compound cytotoxicity using conformal prediction and PubChem HTS data.
    Svensson F; Norinder U; Bender A
    Toxicol Res (Camb); 2017 Jan; 6(1):73-80. PubMed ID: 30090478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
    Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
    SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
    Paricharak S; IJzerman AP; Jenkins JL; Bender A; Nigsch F
    J Chem Inf Model; 2016 Sep; 56(9):1622-30. PubMed ID: 27487177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning.
    Buterez D; Janet JP; Kiddle SJ; Liò P
    J Chem Inf Model; 2023 May; 63(9):2667-2678. PubMed ID: 37058588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
    Paricharak S; IJzerman AP; Bender A; Nigsch F
    ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Screening Assay Datasets from the PubChem Database.
    Butkiewicz M; Wang Y; Bryant SH; Lowe EW; Weaver DC; Meiler J
    Chem Inform; 2017; 3(1):. PubMed ID: 29795804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.
    Kainkaryam RM; Woolf PJ
    BMC Bioinformatics; 2008 May; 9():256. PubMed ID: 18513431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capability.
    Laufkötter O; Sturm N; Bajorath J; Chen H; Engkvist O
    J Cheminform; 2019 Aug; 11(1):54. PubMed ID: 31396716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of chemical libraries for screening.
    Villar HO; Hansen MR
    Expert Opin Drug Discov; 2009 Dec; 4(12):1215-20. PubMed ID: 23480462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformal Regression for Quantitative Structure-Activity Relationship Modeling-Quantifying Prediction Uncertainty.
    Svensson F; Aniceto N; Norinder U; Cortes-Ciriano I; Spjuth O; Carlsson L; Bender A
    J Chem Inf Model; 2018 May; 58(5):1132-1140. PubMed ID: 29701973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliable Prediction Errors for Deep Neural Networks Using Test-Time Dropout.
    Cortés-Ciriano I; Bender A
    J Chem Inf Model; 2019 Jul; 59(7):3330-3339. PubMed ID: 31241929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in functional assays for high-throughput screening of ion channels targets.
    Trivedi S; Liu J; Liu R; Bostwick R
    Expert Opin Drug Discov; 2010 Oct; 5(10):995-1006. PubMed ID: 22823991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.